FDA Inspection
Corixa CorporationCorixa Corporation – FDA Inspection, Mar 12, 2026
Record Details
This FDA Inspection record concerns Corixa Corporation, with an inspection on March 12, 2026, issued by the Philadelphia District Office, covering biologics.
View Company Profile
ID · b3553978-985f-4f9f-adf0-0cb69251dad9
Inspection Facts
- Inspection number
- 1298224
- FDA center
- Biologics
- Project area
- Vaccine, Allergenic, and Live Biotherapeutic Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Corixa Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 15, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 16, 2017 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 13, 2015 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Corixa Corporation
- FDA Inspection 1229084 - 2024-02-09
- FDA Inspection 1091132 - 2019-04-15
- FDA Inspection 1016267 - 2017-05-16
- FDA Inspection 938930 - 2015-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.